Quantcast
Home > Quotes > RMD

ResMed Inc. Common Stock (RMD) Quote & Summary Data

RMD 
$123.75
*  
0.64
0.51%
Get RMD Alerts
*Delayed - data as of Jul. 15, 2019  -  Find a broker to begin trading RMD now
Exchange:NYSE
Industry: Health Care
Community Rating:
View:    RMD Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
119.5
Today's High / Low
$ 124.85 / $ 123.64
Share Volume
531,966
90 Day Avg. Daily Volume
696,823
Previous Close
$ 124.39
52 Week High / Low
$ 124.94 / $ 90.64
Market Cap
17,744,838,086
P/E Ratio
40.18
Forward P/E (1y)
34.38
Earnings Per Share (EPS)
$ 3.08
Annualized Dividend
$ 1.48
Ex Dividend Date
5/8/2019
Dividend Payment Date
6/13/2019
Current Yield
1.19 %
Beta
1.1

Intraday Chart

Shares Traded

Share Volume:
531,966
90 Day Avg. Daily Volume:
696,823

P/E Ratio

P/E Ratio:
40.18
Forward P/E (1y):
34.38
Earnings Per Share (EPS):
$ 3.08

Trading Range

The current last sale of $123.75 is 36.53% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 124.85 $ 124.94
 Low: $ 123.64 $ 90.64

ETFs with RMD as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
2.16% NuShares Enhanced Yield US Aggregate Bond ETF (NUMG) +4.19 (13.91%)
1.13% Principal Price Setters Index ETF (PSET) +3.42 (9.74%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

We are a global leader in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders including sleep disordered breathing, or SDB, chronic obstructive pulmonary disease, or COPD, neuromuscular disease and other chronic diseases. SDB includes obstructive sleep apnea, or OSA, and other respiratory disorders that occur during sleep. Our products and solutions are designed to improve patient quality of life, reduce the impact of chronic disease and lower healthcare costs as global healthcare systems continue to drive a shift in care from hospitals to the home and lower cost settings. Our cloud-based software digital health applications, along with our devices are designed to provide connected care to improve patient outcomes and efficiencies for our customers. Following our formation in 1989, we commercialized a treatment for OSA.  ... More ...  



Risk Grade

Where does RMD fit in the risk graph?


Risk Grade Scale



Consensus Recommendation

Analyst Info